News — Vivaldi Biosciences

News — Vivaldi Biosciences

Posts by Yoy Design Agency

Real-time stability testing of DeltaFLU shows no titer loss after 2 years in storage Influenza pandemic preparedness requires rapid availability of hundreds of millions of doses of an appropriate and effective vaccine. Strategies for p

NewYoy Design AgencyMay 17, 2019

Vivaldi presents data at World Vaccine Congress demonstrating potential of DeltaFLU as universal influenza vaccine – DeltaFLU Outperformed Licensed Vaccine Against Drifted and Shifted Influenza Strains – FORT COLLINS, Colorado – April

NewYoy Design AgencyMay 17, 2019

Vivaldi Biosciences’ Phase 2 Influenza Vaccine Shows Broad Cross-Protection and Superiority in Nonclinical Study FORT COLLINS, Colorado – February 12, 2018 − Vivaldi Biosciences, based at the Research Innovation Center at Colorado Stat

OldYoy Design AgencyMay 17, 2019

Vivaldi Biosciences Board Appoints William Wick as Chief Executive Officer and John Costantino as Chairman Fort Collins, CO – May 22, 2017 - Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing genetically attenu

OldYoy Design AgencyMay 17, 2019

Vivaldi Biosciences Appoints Manfred Reiter, PhD as Senior Vice President, Manufacturing Fort Collins, CO – April 28, 2017- Vivaldi Biosciences Inc., a clinical-stage biotechnology company developing genetically attenuated live influen

OldYoy Design AgencyMay 17, 2019